LogicBio Therapeutics

-$0.01 (-0.24%) As of 6:58 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LOGC and other ETFs, options, and stocks.

About LOGC

LogicBio Therapeutics, Inc. engages in the development of genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination.

CEO
Frédéric Chéreau
Employees
39
Headquarters
Lexington, Massachusetts
Founded
2014

LOGC Key Statistics

Market Cap
151.23M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
131.71K
High Today
$4.34
Low Today
$4.15
Open Price
$4.29
Volume
140.86K
52 Week High
$9.75
52 Week Low
$3.72

LOGC Earnings

-$0.51
-$0.34
-$0.17
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure